1. Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence;Bodenlenz;Clin. Pharmacokinet.,2017
2. FDA Draft Guidance for Industry: Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs. Oct 2022 https://www.fda.gov/media/162471/download.
3. FDA Draft Guidance for Industry: Topical Dermatologic Corticosteroids: In Vivo Bioequivalence. Oct 2023 https://www.fda.gov/media/162457/download.
4. Opportunities and challenges in the diagnostic utility of dermal interstitial fluid;Friedel;Nature Biomed. Eng.,2022
5. How does the Food and Drug Administration approve topical generic drugs applied to the skin?;Ghosh;Dermatol. Clin.,2022